Internal Medicine, Gastroenterology · Pinehurst, NC
NPI
1063456069
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
15 Regional Dr
Pinehurst, NC, 28374
Phone (910) 295-9207
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
22,637 services
Medicare patients, 2024
512
Average age 74
Drug cost, 2024
$1.5M
2,005 prescriptions
Company payments, 2025
$1,312
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David F Martin was code J1439 (injection, ferric carboxymaltose, 1 mg), 12,750 times for 17 patients. In total David F Martin billed 22,637 services in 111 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 12,750 | 17 | $0.86 | $11K |
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 5,700 | 13 | $17.30 | $99K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,430 | 15 | $0.09 | $136 |
| 45385 Colonoscopy - Lesion Removal | Facility | 165 | 165 | $190.83 | $31K |
| 36415 Venipuncture Blood Collection | Office | 157 | 102 | $8.61 | $1,352 |
| 43239 Upper GI Endoscopy | Facility | 113 | 108 | $66.60 | $7,526 |
| 99213 Office E&M - Established | Office | 91 | 81 | $54.59 | $4,968 |
| 99214 Office E&M - Established | Office | 91 | 82 | $83.82 | $7,627 |
| 43450 Digestive/Gastrointestinal | Facility | 86 | 75 | $27.67 | $2,380 |
| 80053 Clinical Chemistry | Office | 81 | 51 | $10.27 | $831 |
| 85025 Blood Count | Office | 67 | 53 | $7.54 | $505 |
| 85651 Clinical Chemistry | Office | 55 | 34 | $4.13 | $227 |
| 86140 Clinical Chemistry | Office | 43 | 26 | $5.08 | $218 |
| 43235 Upper GI Endoscopy | Facility | 42 | 34 | $79.94 | $3,358 |
| 96365 Intravenous Infusion, Hydration | Office | 40 | 32 | $40.90 | $1,636 |
By year: 2022 $264K for 21,517 services; 2023 $256K for 19,976 services; 2024 $221K for 22,637 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 157 | 102 | $8.61 | $1,352 |
| 80053 Clinical Chemistry | 81 | 51 | $10.27 | $831 |
| 85025 Blood Count | 67 | 53 | $7.54 | $505 |
| 85651 Clinical Chemistry | 55 | 34 | $4.13 | $227 |
| 86140 Clinical Chemistry | 43 | 26 | $5.08 | $218 |
| 82607 Clinical Chemistry | 27 | 27 | $14.42 | $389 |
| 85027 Blood Count | 27 | 22 | $6.34 | $171 |
| 82728 Clinical Chemistry | 25 | 24 | $13.00 | $325 |
| 83540 Clinical Chemistry | 23 | 22 | $6.16 | $142 |
| 83550 Clinical Chemistry | 23 | 22 | $8.32 | $191 |
Medicare prescription drug claims, 2024
In 2024, the drug David F Martin prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 198 prescriptions and refills. In total David F Martin wrote 2,005 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 198 | 198 | 194 | $4,928 |
| Rabeprazole Sodium Generic | 184 | 301 | 66 | $6,055 |
| Omeprazole Generic | 129 | 259 | 52 | $2,051 |
| Esomeprazole Magnesium Generic | 96 | 198 | 26 | $2,335 |
| Creon Lipase/Protease/Amylase | 84 | 133 | 19 | $225K |
| Pantoprazole Sodium Generic | 70 | 144 | 24 | $1,278 |
| Prednisone Generic | 59 | 76 | Under 11 | $524 |
| Movantik Naloxegol Oxalate | 58 | 60 | Under 11 | $25K |
| Linzess Linaclotide | 58 | 75 | 19 | $40K |
| Azathioprine Generic | 41 | 91 | 13 | $2,149 |
| Mesalamine Er Mesalamine | 38 | 52 | Under 11 | $10K |
| Famotidine Generic | 36 | 74 | 14 | $757 |
| Colestipol Hcl Generic | 35 | 71 | 12 | $3,499 |
| Lansoprazole Generic | 32 | 49 | Under 11 | $654 |
| Dexlansoprazole Dr Dexlansoprazole | 31 | 50 | Under 11 | $7,865 |
Brand drugs: 548 claims; generic drugs: 1,457 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David F Martin $1,312 ($1,312 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $687.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $687 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $125 |
| Janssen Biotech, Inc. JNJ | 1 | $121 |
| QOL Medical, LLC | 1 | $120 |
| Gilead Sciences, Inc. GILD | 1 | $118 |
| Ardelyx, Inc. ARDX | 2 | $35.75 |
| Pfizer Inc. PFE | 2 | $27.85 |
| Aimmune Therapeutics, Inc. | 1 | $25.62 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $20.2 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $18.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.